REPEAT: Byotrol Plc: Chinese Patent Granted and...
Byotrol plc
Byotrol plc (the 'Company') is pleased to announce that a patent has
been granted in China for its unique biocidal technology, its first for this
country.
The patent has been granted around six months earlier than the Company had been
forecasting and it will enable the Company to pursue a number of global
opportunities it is currently working on, with the confidence that its products
will enjoy patent protection within China.
The Company currently has a number of other patents pending in the Far East
including Singapore and the granting of the Chinese patent follows successful
applications in the UK and South Africa which were granted in 2005 and 2004
respectively. There are currently patents pending for the technology in numerous
other countries including the USA, Europe, Canada and Australia and the Company
expects these to be granted in due course.
The successful patent application follows the recent announcements of EPA
approval in the USA and CE Mark approval in Europe and will enable sales of
Byotrol technology in China to proceed under patent protection.
The Company is currently engaged in discussions with a number of global
companies regarding deployment of Byotrol's technology and is pleased to able to
announce it has secured significant contracts in the industrial and food
processing sectors. The Directors consider these contracts demonstrate both the
efficacy of Byotrol's technology and the ability of the management team to
engage with major global organisations.
Becker Industrial Coatings, one of the world's leading industrial coatings
manufacturers has launched a range of anti-microbial coatings containing Byotrol
under the BeckryShield brand name. The launch follows extensive trials
undertaken to test the efficacy of Byotrol's technology and the BeckryShield
range offers effective anti-microbial protection for up to 2 years. The Company
will receive revenues from the sale of concentrate and a royalty on sales
achieved.
The Company has recently shipped its first customer order to Gold Kist, one of
America's largest poultry processing companies, which is using Byotrol
technology as part of its hygiene regime initially in its South Carolina
processing plant.
Commenting on the successes, Byotrol Deputy Chairman Stephen Falder said:
'Securing the patent in China and winning significant contracts are the latest
in a series of milestones for the Company. Importantly they are indicative of
the consistent progress with product approvals and protection we are making as
well as our ability to work successfully with major organisations. Based on work
currently being undertaken and progress to date, the board is increasingly
optimistic about future prospects for growth in our chosen market sectors.'
Financial calls to:
Stephen Falder 07767 404629
Deputy Chairman 0161 277 9518
Byotrol plc
David McRobbie 07739 549226
Chief Executive
Byotrol plc
Charles Stanley Securities 020 7149 6457
Philip Davies
Media Calls to:
Allan Piper 0207 436 7486
First City PR
Jim Rothnie
McCann Erickson PR 01625 822540
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.